Bana-ag, Corazon .
HRN: 23-54-71 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/20/2023
CEFTAZIDIME 1GM (VIAL)
08/20/2023
08/27/2023
IV
1g
Q8H
CAP MR; PTB Relapse
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes